By IDSE News Staff
Scientists have produced and tested, in mice, a vaccine that protects against a hypervirulent form of the bacteria Klebsiella pneumoniae, according to researchers at Washington University School of Medicine in St. Louis and VaxNewMo, a St. Louis–based startup (Proc Natl Acad Sci U S A [Epub Aug 27, 2019] https://doi.org/10.1073/pnas.1907833116).
K. pneumoniae causes a variety of infections including rare but life-threatening liver, respiratory tract, bloodstream and